This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1988:141:149-56.

doi: 10.1007/978-3-642-74006-0_20.

Altered growth phenotype of a Burkitt's lymphoma line following the introduction and stable expression of the EBNA 2A gene

J Gordon, M J Millsum, M Finney, J A Cairns, G R Guy, C D Gregory, S D Abbot, A B Rickinson, F Wang, E Kieff

PMID: 3215047
DOI: 10.1007/978-3-642-74006-0_20

Altered growth phenotype of a Burkitt's lymphoma line following the introduction and stable expression of the EBNA 2A gene

J Gordon et al. Curr Top Microbiol Immunol. 1988.

. 1988:141:149-56.

doi: 10.1007/978-3-642-74006-0_20.

Authors

J Gordon, M J Millsum, M Finney, J A Cairns, G R Guy, C D Gregory, S D Abbot, A B Rickinson, F Wang, E Kieff

PMID: 3215047
DOI: 10.1007/978-3-642-74006-0_20

No abstract available

PubMed Disclaimer

Similar articles

Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4.
Silins SL, Sculley TB. Silins SL, et al. Int J Cancer. 1995 Jan 3;60(1):65-72. doi: 10.1002/ijc.2910600110. Int J Cancer. 1995. PMID: 7814154
Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4.
Silins SL, Sculley TB. Silins SL, et al. Virology. 1994 Jul;202(1):16-24. doi: 10.1006/viro.1994.1317. Virology. 1994. PMID: 8009829
New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB. Young LS, et al. J Gen Virol. 1987 Nov;68 ( Pt 11):2853-62. doi: 10.1099/0022-1317-68-11-2853. J Gen Virol. 1987. PMID: 2824665
Epstein-Barr virus sustains Burkitt's lymphomas and Hodgkin's disease.
Hammerschmidt W, Sugden B. Hammerschmidt W, et al. Trends Mol Med. 2004 Jul;10(7):331-6. doi: 10.1016/j.molmed.2004.05.006. Trends Mol Med. 2004. PMID: 15242681 Review.
The epidemiology of Burkitt's lymphoma: evidence for a causal association with Epstein-Barr virus.
De-Thé G. De-Thé G. Epidemiol Rev. 1979;1:32-54. doi: 10.1093/oxfordjournals.epirev.a036213. Epidemiol Rev. 1979. PMID: 232877 Review. No abstract available.

See all similar articles

Cited by

Identification of a sub-population of B cells that proliferates after infection with Epstein-Barr virus.
Megyola C, Ye J, Bhaduri-McIntosh S. Megyola C, et al. Virol J. 2011 Feb 25;8:84. doi: 10.1186/1743-422X-8-84. Virol J. 2011. PMID: 21352549 Free PMC article.
Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
Abbot SD, Rowe M, Cadwallader K, Ricksten A, Gordon J, Wang F, Rymo L, Rickinson AB. Abbot SD, et al. J Virol. 1990 May;64(5):2126-34. doi: 10.1128/JVI.64.5.2126-2134.1990. J Virol. 1990. PMID: 2157875 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer